N(6)-methyladenosine (m(6)A) modification is an important mechanism in microRNA processing and maturation. Previous studies show the involvement of pri-miRNA methylation in regulating the occurrence and development of tumor-related diseases. In this study, we investigated the role of its aberrant regulation in cardiac diseases. Myocardial infarction (MI) mouse were established by ligation of the left anterior descending branch of the coronary artery. We showed that the expression of methyltransferase 14 (METTL14) was significantly increased in myocardium of MI mice. We demonstrated that METTL14 methylated the primary transcript miRNA (pri-miR-5099), promoting the recognition by DiGeorge critical region 8 (DGCR8) and the maturation processing of pri-miR-5099. Mature microRNA-5099-3p (miR-5099-3p) inhibited the expression of E74 like ETS transcription factor 1 (ELF1), which transcriptionally regulated pyroptosis factors such as acysteinyl aspartate-specific proteinase 1 (caspase-1) and gasdermin D (GSDMD), ultimately leading to cardiomyocyte pyroptosis. This study reveals that myocardial infarction-induced miR-5099-3p excessive maturation via m(6)A modification promotes the development and progression of cardiomyocyte pyroptosis.
METTL14-mediated m(6)A methylation of pri-miR-5099 to facilitate cardiomyocyte pyroptosis in myocardial infarction.
METTL14介导的pri-miR-5099的m(6)A甲基化促进心肌梗死中心肌细胞的焦亡
阅读:13
作者:Yu Hang, Li Qing-Sui, Guo Jun-Nan, Zhang Zhen, Lang Xian-Zhi, Liu Yi-Ning, Qin Long, Su Xu, Zhang Qing-Wei, Xue Ya-Dong, Gong Li-Ling, Xu Ning, Li Ming, Zhao Wen-Shuang, Zhao Xing-Miao, Zhang Wan-Yu, Yao Yi-Jing, Chen Xi-Ming, Zhang Zhen, Li Wei, Wang Han-Xiang, Cai Ben-Zhi, Li Jia-Min, Wang Ning
| 期刊: | Acta Pharmacologica Sinica | 影响因子: | 8.400 |
| 时间: | 2025 | 起止号: | 2025 Jun;46(6):1639-1651 |
| doi: | 10.1038/s41401-025-01485-y | 研究方向: | 细胞生物学 |
| 疾病类型: | 心肌炎 | 信号通路: | DNA甲基化 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
